41. PP.26.13: NITROGLYCERIN-MEDIATED, BUT NOT FLOW-MEDIATED VASODILATION, IS ASSOCIATED WITH BLUNTED NOCTURNAL BLOOD PRESSURE FALL IN PATIENTS WITH RESISTANT HYPERTENSION. (June 2015) Authors: Salles, G.; Fontes-Guerra, P.; Cardoso, C.; Muxfeldt, E. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA. (June 2017) Authors: Blakemore, S.J.; Daigle, S.R.; McDonald, A.A.; Morschhauser, F.; Ribrag, V.; Salles, G.; McKay, P.; Tilly, H.; Schmitt, A.; Le Gouill, S.; Fruchart, C.; Radford, J.; Zinzani, P.L.; Assouline, S.; Cartron, G.; Dickinson, M.; Morin, R.; Wu, H.; Sausen, M.; Clawson, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND). (12th June 2019) Authors: Salles, G.; Duell, J.; González Barca, E.; Jurczak, W.; Liberati, A.M.; Nagy, Z.; Obr, A.; Gaidano, G.; Andre, M.; Kalakonda, N.; Dreyling, M.; Zinzani, P.L.; Dirnberger‐Hertweck, M.; Weirather, J.; Ambarkhane, S.; Maddocks, K. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. PROGNOSTIC MODEL FOR HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA INCLUDING BASELINE TOTAL METABOLIC TUMOR VOLUME AND END INDUCTION PET: a POOLED ANALYSIS FROM LYSA AND FIL TRIALS. (June 2017) Authors: Cottereau, A.; Versari, A.; Dupuis, J.; Chartier, L.; Menga, M.; Casasnovas, R.; Haioun, C.; Tilly, H.; Tarantino, V.; Dubreuil, J.; Federico, M.; Salles, G.; Luminari, S.; Trotman, J.; Meignan, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM. (12th June 2019) Authors: Thieblemont, C.; Le Gouill, S.; Di Blasi, R.; Cartron, G.; Morschhauser, F.; Bachy, E.; Paillassa, J.; Bernard, S.; Tessoulin, B.; Gastine, T.; Fegueux, N.; Kanouni, T.; Manier, S.; Sesques, P.; Houot, R.; Haouin, C.; Tilly, H.; Salles, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. REAL‐WORLD TREATMENT PATTERNS AND OUTCOMES OF 3455 PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA PATIENTS IN US ROUTINE CLINICAL PRACTICE. (17th June 2021) Authors: Kumar, A.; Martin, P.; Wang, M.; Qi, K.; Daly, K.; Parisi, L.; Zhu, A.; Salles, G. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. REFINEMENT OF MUM1 EXPRESSION THRESHOLD FOR DOUBLE POSITIVE CD10+ MUM1+ DIFFUSE LARGE B CELL LYMPHOMA ALLOWS A BETTER CELL OF ORIGIN CLASSIFICATION FOR GCB SUBTYPE. (12th June 2019) Authors: Bossard, C.; Laghmari, O.; Le Bris, Y.; Bonnet, A.; Moreau, A.; El Alami Thomas, W.; Pavageau, A.; Guerzider, P.; Maisonneuve, H.; Ruminy, P.; Bene, M.; Casasnovas, O.; Canioni, D.; Thieblemont, C.; Petrella, T.; Jardin, F.; Salles, G.; Tilly, H.; Gaulard, P.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Rituximab maintenance after autologous stem‐cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group. (June 2017) Authors: Le Gouill, S.; Thieblemont, C.; Oberic, L.; Moreau, A.; Bouabdallah, K.; Dartigeas, C.; Damaj, G.; Gastinne, T.; Ribrag, V.; Feugier, P.; Casasnovas, O.; Zerazhi, H.; Haioun, C.; Maisonneuve, H.; Van Den Neste, E.; Tournilhac, O.; Le Dû, K.; Morschhauser, F.; Cartron, G.; Fornecker, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY. (12th June 2019) Authors: Delfau‐Larue, M.H.; Boulland, M.L.; Feugier, P.; Maisonneuve, H.; Casasnovas, O.; Haioun, C.; Pica, G.M.; Lamy de la Chapelle, T.; Ysebaert, L.; Tilly, H.; Eisenmann, J.C.; Le Gouil, S.; Ribrag, V.; Jardel, H.; Glaisner, S.; Cartron, G.; Salles, G.; Xerri, L.; Fest, T.; Morschhauser, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. ROLE OF UP‐FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMAS: a PROPENSITY SCORE MATCHING ANALYSIS OF PATIENTS FROM LYSA CENTERS. (June 2017) Authors: Fossard, G.; Broussais, F.; Coelho, I.; Bailly, S.; Nicolas‐Virelizier, E.; Toussaint, E.; Lancesseur, C.; Lebras, F.; Willems, E.; Tchernonog, E.; Delarue, R.; Gressin, R.; Chauchet, A.; Gyan, E.; Cartron, G.; Bonnet, C.; Haioun, C.; Damaj, G.; Gaulard, P.; Fornecker, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗